translation agency

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update
Public Health: Bad Blood Between Red Cross and FDA
Gershon, Diane
July 19, 1990
Nature (07/19/90) Vol. 346, No. 6281, P. 210

Last week the House subcommittee on oversight and investigations, led by Rep. John Dingell (D-Mich.), heard allegations by the Food and Drug Administration (FDA) that the Red Cross allowed reports of several hundred instances of errors or accidents in blood collection and distribution to languish at its national headquarters in Washington, D.C., rather than reporting them to the FDA. The committee set out to evaluate the safety of the nation's blood supply and to determine if the Red Cross learned its lesson from the early 1980s, when slow response to the HIV epidemic impaired public confidence in the blood supply. The FDA charged that the Red Cross was slow or failed to report 386 cases despite a mandate that such reports be made promptly. The Red Cross said it will provide a written response to the charges in 60 days.

www.aegis.org